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Background: Klebsiella pneumoniae strains expressing ESBLs are a predominant cause of hospital acquired
infections. Here we describe the molecular epidemiology of these isolates in a tertiary hospital in Tanzania, as
potential pathogens for neonatal infections.
Methods: Between April 2009 and March 2010 all Klebsiella pneumoniae isolates with phenotypic expression
Extended Spectrum Beta Lactamase (ESBL) were collected and characterized. Identification was done using in house
biochemical tests in case of ambiguous results confirmation was done using API 20E. Susceptibility testing was
determined using the disc diffusion method followed by specific PCR and sequencing to determine ESBL genes.
Phylogenetic analysis, Pulse field gel electrophoresis (PFGE) and Multi-Locus sequence typing (MLST) to PFGE
clusters representative isolates were performed to determine clones of the isolates. Conjugation and hybridization
were performed to determine the location of blaCTX-M-15 gene.
Results: A total of 92 non- repetitive ESBL producing K. pneumoniae representing 50.3% of Klebsiella pneumoniae
isolates were characterized. These isolates were from blood 61 (66%), wound swab 13 (14%), urine 12 (13%) and
pus 6 (7%) were analyzed. Most blood culture strains originated from neonatal unit 39/61(64%) and 22 (36%) of the
blood culture isolates were from neonatal ICU. All isolates were resistant to gentamicin and 54% were resistant to
ciprofloxacin. Using a similarity index of 80%, the isolates were assigned to thirteen clusters based on PFGE patterns
and contained sub-clusters with identical strains indicating clonal outbreaks. Cluster X5, X7 and X8, and X9 were
grouped into ST48, ST14 and ST348 respectively. Based on gyrA PCR- RFLP phylogenetic analysis all isolates were
grouped as KpI. The predominant ESBL allele detected was blaCTX-M-15 which was found in 76% of isolates, followed
by blaTEM-104 (19%), blaSHV-11 (3.2%) and blaTEM-176 (2%). The blaCTX-M-15 gene was located in multiple conjugative
IncF plasmids ranging from 25 kb-485 kb in size.
Conclusion: The high prevalence of blaCTX-M-15 observed among ESBL producing K. pneumoniae in Tanzania, is
possibly due to the spread of a common IncFII 145 kb plasmid and of certain clones such as ST14 and ST48.
Furthermore the 485 kb plasmid detected is the largest plasmid reported to carry blaCTX-M-15 todate.* Correspondence: can.imirzalioglu@mikrobio.med.uni-giessen.de
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Gram negative bacteria from clinical settings are in-
creasingly becoming resistant to commonly used anti-
biotics. Prevalence of extended spectrum β-lactamases
in clinical Klebsiella pneumoniae has been reported to
be 45-80% in Tanzania [1,2]. While blaCTX-M-15 is the
most common ESBL allele among Escherichia coli in
Tanzania [3-5], little is known about ESBL alleles in K.
pneumoniae. In Tunisia blaCTX-M-15 was the predom-
inant allele among K. pneumoniae isolates and was
found in association with IncF plasmids [6]. The exces-
sive use of cephalosporins in clinical practice has
resulted in an increase of gram-negative enteric bac-
teria resistant to these drugs. ESBL genes responsible
for resistance are mainly found in mobile genetic ele-
ments that can readily spread through bacterial popu-
lations [7-9]. ESBL –producing K. pneumoniae usually
express resistance to various antibiotics [3,6-9], there-
fore their antibiotic therapy is limited to a few expen-
sive drugs which, in most cases, are not available in
developing countries.
The distribution of ESBL alleles varies among coun-
tries. The isolation of blaSHV- and blaCTX-M-producing
K. pneumoniae has been demonstrated in different
multicentre studies [10] and, as in E. coli, the dissemin-
ation of ESBLs is due to clonal expansion and/or plas-
mid transfer [11,12]. Dissemination of major blaCTX-M-15
producing K. pneumoniae epidemic clones ST11, ST15,
ST147 and ST258 has been reported in Europe, North
America and Asia [11,12]. Very few studies have reported
on the problem of ESBL producing K. pneumoniae in
Africa especially in sub-Saharan Africa [4,5,13]. In
Tanzania blaCTX-M-15 has been demonstrated in one
strain of K. pneumoniae [5]. Despite the high preva-
lence of these isolates in nosocomial infections, large
studies to investigate the molecular epidemiology of
these isolates in Tanzania are still lacking. We there-
fore conducted an epidemiological study to determine
the molecular epidemiology of ESBL producing K.
pneumoniae within the largest tertiary hospital in the
Lake Zone of Tanzania.
Methods
Bacterial strains and susceptibility testing
Between April 2009 and March 2010 a total of 1260
clinical specimens were processed of which 700 were
from adults, 600 from neonates and 60 from children.
One hundred and three non repetitive ESBL producing
Klebsiella pneumoniae were obtained from these routine
clinical specimens; [blood (61), wound swab (13), urine
(12) and pus (6)] were analyzed. All inpatient’s speci-
mens were obtained after a hospitalization time of more
than 72hrs. The specimens were processed using standard
operative procedures; K. pneumoniae isolates were identifiedusing in-house biochemical profiles which included: Triple-
Sugar-Iron, Urease, Voges-Prosgauer, Methyl-Red, cit-
rate utilization, indole production and motility. In case
of ambiguous results a further identification using API
20E (BioMerieux, France) was done following the in-
structions of the vendor. Antibiotic susceptibility was de-
termined using disk diffusion method on Mueller-Hinton
agar (Oxoid, Thermo Scientific, UK) as recommended by
the Clinical and Laboratory Standard Institute (CLSI) [14].
Susceptibility was tested to 11 antibiotics: ampicillin (10
μg), amoxicillin/clavunate (20/10 μg), tetracycline (30 μg),
gentamicin (10 μg), sulfamethoxazole-trimethoprim (1.25/
23.75 μg), ciprofloxacin (5 μg), ceftazidime (30 μg),
cefepime (30 μg) and meropenem (10 μg) (OXOID,
Thermo Scientific, UK). Quality control was performed
using Escherichia coli ATCC 25922 reference strain.
ESBL screening was performed using MacConkey agar
with 30 μg/ml cefotaxime and then confirmed using
double disk synergy (Disk approximation method) [9].
Escherichia coli ATCC 25922 was utilized as negative
control whereas Klebsiella pneumoniae ATCC 700603
was used as ESBL positive control.
Characterization of ESBLs genes
The presence of ESBL genes was determined by PCR and
sequencing using primers targeting blaTEM, blaSHV and
blaCTX-M as described previously [9]. Briefly, strains were
grown on Luria- Bertani (LB) agar plates with 30 μg/ml
cefotaxime and a single colony was used as template in 50
μl PCR mixture as previously described [9]. In all
transconjugants the presence of tnpA/ISEcp1 (1.881 kb)
was tested by PCR using primers (tnpA F: 5’-GCAGG
TGATCACAACC-3’ and tnpA R: 5’-GCGCATACAGC
GGCACACTTCCTAAC-3’) as previosuly described [9].
All PCR products were sequenced (LGC genomics GmbH,
Berlin, Germany) using the same primers plus an add-
itional set of primers (CTF-F: 5’-GACAGACTATTCAT
GTTGTTG-3’ and CTF-R:5’-CGATTGCGGAAAAGCAC
GTC-3’) designed in this study to cover mutations that dif-
ferentiate blaCTX-M-15 from blaCTX-M-28 [15]; the resulting
sequence was compared with known sequences using
DNASTAR software (DNASTAR Inc, Madison, USA) and
the NCBI BLAST algorithm.
Pulsed-field Gel Electrophoresis (PFGE), phylogenetic
group typing and MLST
Clonal relatedness between the different strains was
studied using PFGE which was performed according to
the Pulse Net protocol of the Centre for Disease Control
and Prevention (Atlanta, USA). The agarose-embedded
DNA was digested with the restriction endonuclease XbaI
(Fermentas, Germany) at 37°C for 18hrs. Electrophoresis
was conducted using CHEF Drive II (Bio-Rad, UK); condi-
tions were 6V, with 5s-50s pulses for 26hrs. Band patterns
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Belgium). Patterns were normalized using a molecular
weight marker (Lambda Ladder PFGE Marker, New
England Biolabs, USA) [3,9].
Phylogenetic grouping was performed using a rapid
method combining gyrA PCR- restricted fragment length
polymorphisms analysis (RFLP), parC-PCR and adonitol
fermentation as described previously [16]. MLST was
performed as described previously for 15 selected isolates
based on PFGE clusters [17] (http://www.pasteur.fr/
recherche/genopole/PF8/mlst/Kpneumoniae.html). Briefly,
PCR for seven housekeeping genes; rpoB, gapA, mdh, pgi,
phoE, infB and tonB was conducted and products directly
sequenced. Analysis was carried out as described on the
website.
Location of ESBL genes
Conjugation was performed to investigate the transferability
of the resistance determinants using plate mating experi-
ments as described previously [9]. Eighteen K. pneumoniae
from different PFGE clusters were used as donor and E. coli
K12 CC118 (RifR, StrR, Lac-, plasmid-free) as a recipient
strain. Transconjugants were selected on Luria Bertani/ ly-
sogeny broth (LB) agar plates supplemented with 30 μg /mL
cefotaxime and 300 μg /mL rifampicin and were confirmed
for the presence of ESBL genes phenotypically, using the
double disk synergy test (DDST) disk approximation method
and genotypically, by testing for the presence of the respect-
ive ESBL gene via PCR. The frequency of conjugation was
expressed relative to the number of donor cells.
Plasmid sizing was performed on clinical isolates and
transconjugants using S-1 nuclease PFGE as described
previously [9]. Southern blotting was performed using
overnight capillary transfer (CUMC Protocol for Southern
Blot, New York) and hybridization was accomplished
using a blaCTX-M-15 DIG labelled probe (DIG High Prime
DNA Labelling and Detection Starter Kit II, Roche,
Germany) following the manufacturer’s instructions.
PCR based replicon typing with confirmatory sequen-
cing was carried out with selected isolates and their
transconjugants using primers pairs which recognize
FIA, FIB, FII, FrepB, I1, P, A/C, X, HI1,HI2, L/M, FIC, Y,
W,T, K and N replicons [7].
Ethical approval
The study was approved by the Bugando Medical Cen-
ter/Catholic University of Health and Allied Sciences
ethics committee and drug susceptibility results were
used for routine patient care.
Results
Bacterial strains and susceptibility pattern
A total of 92 K. pneumoniae isolates were confirmed to
be ESBL producers, they represented 50.3% of all K.pneumoniae isolated over a period of 12 months. Most of
K. pneumoniae producing isolates were from inpatients 87
(94%). The majority of isolates were recovered from blood
culture samples from neonatal unit and neonatal ICU
(NICU) 59 (64%) (Figure 1). Nineteen isolates (21%)
were from wound swabs and pus and twelve (13%)
were isolated from urine specimens from various wards
(Figure 1). A higher rate of resistance to commonly
used non-beta lactams was observed. All isolates were
resistant to gentamicin and sulphamethaxazole/tri-
methoprim; the rate of resistance to tetracycline and
ciprofloxacin was 98% and 54% respectively. A total of
25 (38%) isolates from neonatal unit and NICU were
resistant to ciprofloxacin compared to 17 (68%) of iso-
lates from other wards (chi-square 5.29, (p = 0.02)). All
isolates were sensitive to meropenem using the disc
diffusion test (Table 1).
ESBL alleles
Of 103 phenotypically confirmed ESBL producing Klebsi-
ella pneumoniae isolated during study period 92 (89%)
were PCR-positive using the primers (CTX-M, TEM,
SHV) described in the materials and methods section. Fol-
lowing PCR and sequencing blaCTX-M-15 was the com-
monest ESBL allele detected. It was found in 70 (76%) of
cases. In a majority of isolates 49 (70%), the blaCTX-M-15
allele occurred in combination with blaTEM-1. Also
blaCTX-M-15 occurred in combination with blaSHV-11 in
11 (16%) isolates. Other ESBL alleles detected were
blaTEM-104 (18%) and blaTEM-176 (2%). BlaCTX-M-15 was the
most frequent allele (87%) among isolates from neonatal
unit and NICU (Figure 1). In all 18 strains tested the
ISEcp1/tnpA element was found upstream of blaCTX-M-15
.
Genetic relatedness
The PFGE-based patterns of the isolates were assigned to
13 clusters using a similarity index (SAB) of 0.8 Figure 1.
These clusters contained sub-clusters, as shown in
Figure 1.Cluster X5 which was assigned to ST48 was
found to be clonal. The cluster X7 contained 2 large
sub-clusters each with identical strains; one sub-
cluster was assigned to ST48 and the other to ST14.
All these sub-clusters with identical strains occurred
in the neonatal unit and NICU, thus representing out-
breaks in these units. The first outbreak occurred in
June 2009 isolates in cluster X8, followed by sub-
clusters in X7 in January and March 2010. The largest
cluster was cluster X7 which contained 28 isolates of
which 26 (93%) were from the neonatal unit and
NICU. The isolates in this cluster have a single differ-
ing fragment thus indicating their close relatedness.
The cluster X2, as the second largest, contained di-
verse isolates from various wards and could further be
divided into 4 sub-clusters. Representative strains from
NO Ward Specimen ESBL ALLELE Phyl Cluster
X
Figure 1 PFGE dendrogram of ESBL–producing Klebsiella pneumoniae. The PFGE patterns of the 92 K. pneumoniae ESBL producers are
displayed on the dendrogram. The diagram also shows the isolate numbers, wards, specimens, ESBL alleles, phylogenetic groups as well as the
PFGE cluster. Dashed X line indicates SAB of 0.8 revealing 13 clusters (X1-X13). NU, neonatal unit; NICU, neonatal intensive care unit.
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Table 1 Susceptibility profile of 92 ESBL producing Klebsiella pneumoniae isolates
Antibiotic %resistance Mean zone diameter ± SD: resistance Mean diameter ± SD: sensitive
Ampicillin (30 μg) 100% 6.06 ± 0.2356 mm NA
Amoxicillin/Clavulanate(20/10 μg) 100% 10.7 ± 0.428 mm NA
Tetracycline (30 μg) 98% 6 ± 0.000 mm 17 mm
Gentamicin (10 μg) 100% 6.22 ± 0.428 mm NA
SXT(1.25/23.75 μg) 100% 6.56 ± 0.856 mm NA
Ciprofloxacin (5 μg) 54% 8.67 ± 0.485 mm 23.44 ± 0.511 mm
Ceftazidime (30 μg) 100% 13.78 ± 0.428 mm NA
Cefepime (30 μg) 95.7% 11.3 ± 2.6 mm 22.0 ± 2.8 mm
Meropenem (10 μg) 0.00% NA 24.4 ± 0.3 mm
NA = not applicable.
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X9 with 6 isolates was assigned to ST348. All K.
pneumoniae isolates were grouped in the phylogenetic
group KpI using gyrA PCR-RFLP.
Location of bla CTX-M-15 genes and transferability
of resistance
Sixteen of 18 Klebsiella pneumoniae isolates, which
were randomly selected as donors, were able to trans-
fer resistance at a frequency of 10-3-10-7 trans-
conjugants per donor cell (Table 2). Different sizes of
plasmids were found in clinical isolates ranging fromTable 2 Phenotypic and molecular characteristics of 18 repre
S NO Isolate ESBL allele Inc group PFGE cluster ST Ph
1 020 CTX-M-15, TEM-1 FII X2 ST147 Kp
2 019 CTX-M-15, TEM-1 FII X2 ND Kp
3 025 TEM-104 FII X2 ST101 Kp
4 024 TEM-104 ND X8 ST14 Kp
5 028 CTX-M-15, TEM-1 FII X8 ST14 Kp
6 175 CTX-M-15 FII X10 ND Kp
7 071 CTX-M-15, TEM-1 ND X2 ST101 Kp
8 008 CTX-M-15, TEM-1 FIA X7 ST14 Kp
9 107 TEM-104 FII X8 ST14 Kp
10 108 TEM-104 FIA X12 ND Kp
11 214 CTX-M-15, TEM-1 ND X7 ST48 Kp
12 120 CTX-M-15, TEM-1 FII X9 ST348 Kp
13 133 CTX-M-15 FII X2 ND Kp
14 135 CTX-M-15 FII X4 ND Kp
15 141 CTX-M-15, TEM-1 ND X9 ST348 Kp
16 211 CTX-M-15,TEM-1 ND X5 ST48 Kp
17 118 CTX-M-15 ND X7 ST14 Kp
18 081 CTX-M-15 FII X2 ND Kp
Inc = Incompatibility; ST = Sequence Type; Phyl = Phylogenetic group; S NO = Strain
TET = tetracycline.
ND = not determinable.25 kb-485 kb in size and all were found to hybridize to
the DIG labelled blaCTX-M-15 probes. A commonly
identified 145 kb IncF plasmid was detected in 8 (44%)
of the isolates tested. A representative isolate from 11
identical strains in cluster X7 contained 2 plasmids
(485 kb and 25 kb). Interestingly this isolate did not
transfer resistance by conjugation and both plasmids
gave positive signals on hybridization (Figure 2). IncF
replicons were found in 12 isolates (66.6%). Gentami-
cin resistance was transferable in all conjugative cases,
Gentamicin-co-trimoxazole (GM-SXT) in 7 (38%), and
GM-SXT-TET (Tetracycline) in 3 (16%) cases.sentative strains of Klebsiella pneumoniae used as donors
yl Conjugation frequency Plasmid size Transferable resistance
I 10-5 145 kb GM,SXT
I 10-7 194 kb GM
I 10-7 145 kb GM,SXT
I 10-6 194 kb GM
I 10-6 145 kb GM
I 10-5 97 kb GM
I 10-6 485 kb GM
I 10-5 97 kb GM
I 10-5 194 kb GM
I 10-3 97 Kb GM
I Neg 485 Kb, 25 kb -
I 10-6 145 kb GM,SXT
I 10-7 145 kb GM,SXT,TET
I 10-3 145 kb GM,SXT, TET
I 10-5 145 kb GM,SXT
I Neg - -
I 10-7 97 kb GM,SXT
I 10-6 145 kb GM
number; GM = gentamicin; SXT = sulfamethoxazole-trimethoprim;
Mshana et al. BMC Infectious Diseases 2013, 13:466 Page 6 of 8
http://www.biomedcentral.com/1471-2334/13/466Discussion
The results of this study provide insights into the mo-
lecular epidemiology of ESBL producing K. pneumoniae
isolates in a single tertiary hospital in Tanzania, thereby
representing the first large-scale study to characterize
ESBL producing K. pneumoniae in Tanzania. A high rate
of ESBL producing K. pneumoniae isolates is observed
as described in various studies [18-21]. The majority of
the isolates characterized in this study were from the
neonatal- and its intensive care- units. Infections caused
by ESBL-producing organisms in neonates are usually
reported to be hospital-acquired and associated with in-
vasive procedures [20,22,23]. The predominance of these
isolates in these units could be explained by the high use
of the third generation cephalosporins, as cefotaxime
was the most prescribed drug in the unit during study
period. This could further be supported by a significantly
(p < 0.05) low rate of resistance towards ciprofloxacin in
the neonatal unit and NICU compared to the other
wards as ciprofloxacin is usually contraindicated in neo-
nates and children. These units have a high rate of em-
pirical treatment using ampicillin plus gentamicin as
first line and cefotaxime as second line antibiotic treat-
ments [20]. As in other studies [22,24] all isolates were
found to be resistant to gentamicin and in all cases gen-
tamicin resistance was transferable by conjugation, thus
eliminating gentamicin as a treatment option for ESBL






Figure 2 S1 nuclease PFGE-based sizing of large plasmids for 8 clinica
large plasmids for 8 isolates. M indicates the Lambda molecular weight ma
214 and 175 reveal plasmids with sizes ranging from 25 kb to 485 kb whic
southern blotting and DIG hybridization. Hybridized plasmids are indicated
was determined after digestion with HindIII, BamHI and EcoRI (data not shomeropenem but due to high costs this drug is not com-
monly used in this hospital.
There is a significant difference in the isolation rate of
ESBL-producing K. pneumoniae between this study and
other studies done previously in Tanzania. This may be
due to a variation in the epidemiology of ESBL produ-
cing organisms between the hospitals [10]. As in previ-
ous studies [25-27] the blaCTX-M-15 allele associated with
ISEcp1 was carried on multiple conjugative plasmids of
different sizes ranging from 25 kb-485 kb, with one
clone having multiple copies of blaCTX-M-15 genes, one
copy in the chromosome and two other copies in a 485 kb
and a 25 kb plasmid This reflects transmission dynamics
of this element, comprising of intra strain mobility on dif-
ferent genetic entities (chromosome, plasmids) within a
single isolate, in addition to inter- strain and inter-species
transmissibility. Multiple ESBL alleles were observed in
which blaCTX-M-15 and blaSHV-11 co-existed in one clone
in the neonatal unit; this has recently been described in
clinical isolates in Poland as a new strategy of K.
pneumoniae to confer resistance to antibiotics [28]. There
is an antibiotic selection advantage for the isolates with
multiple alleles and multiple copies of genes for an allele
as seen in cluster X7 in this study.
A high diversity of ESBL producing K. pneumoniae
was observed using PFGE and isolates could be divided
in 13 clusters at 80% similarity with multiple sub-
clusters. In contrast MLST of three large clusters withSP
175214141135020175 008 025
B)
l isolates. A) Agarose gel showing S1 nuclease PFGE-based sizing of
rker. Plasmid size preparations from isolate number 08, 20, 25, 135, 141,
h are indicated with arrowheads; B) shows the corresponding gel after
with arrowheads. A small plasmid is labeled with SP; its size of 25 kb
wn).
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three sequence types 14, 48 and 348; compared to previ-
ous reported ST11 and ST15 [19,27,29]. The detection
of K. pneumoniae ST14 and ST48 carrying blaCTX-M-15
in a single hospital associated with neonatal nosocomial
infection are the first description of the sequence types
on the African continent. ST14 and ST48 carrying
blaCTX-M-15 could be the predominant clones in Africa,
a finding which has to be clarified by further studies
from different African countries and underscores the
need for joint efforts to survey ESBL-producing isolates
in Africa. Recently in Oman a ST14 isolate has been
found to harbor blaCTX-M-15 and blaNDM-1, also a
ST14 K. pneumoniae carrying blaCTX-M-15 with a similar
resistance pattern as described here has been isolated in
two patients in Spain from rectal swabs [27]. ST147 and
ST101 were detected in cluster X 2 which is the most di-
verse cluster. These sequence-types have been reported
to occur worldwide and are associated with multi-
resistant K. pneumoniae [28,29].
Clonal outbreaks caused by ST14 and ST48 were dis-
cernible by PFGE. All outbreaks occurred in the neo-
natal unit and neonatal ICU at different time-points
and could be due patient to patient transmission or the
acquisition from a common source (contaminated equip-
ments) or from healthcare workers [28-30]. Different clones
were involved in all three outbreaks; this further supports
the high diversity of these strains in this setting, and
represents a huge challenge for the local hospital infec-
tion control team. Constant surveillance, sustainable
hygiene measures and accurate detection in the hos-
pital are crucial for a quick and appropriate manage-
ment of these outbreaks [31]. This approach has been
used in most developed countries, but can be difficult
to implement in a country like Tanzania where avail-
ability of even routine culture and susceptibility testing
is a major challenge in many hospitals. There is also a
need for the hospitals to institute an antibiotic policy
guided by antimicrobial stewardship measures such as
adaption of empirical treatment regimens to hospital
epidemiological susceptibility data. Despite of the fact
that these isolates were collected 2009–2010, no major
intervention could be instituted until now to control
the problem and therefore molecular epidemiology of
these isolates is expected to have remained more or less
unchanged for the past 3 years.
Conclusion
This study highlights the need to establish an antimi-
crobial resistance surveillance network in Tanzania for K.
pneumoniae and other ESBL-producing Enterobacteriaceae
to monitor the trends and new types of resistance me-
chanisms emerging in hospitals. Also, the factors respon-
sible for the selection and dissemination of this plasmidencoding the blaCTX-M-15 and multiple clones carrying
blaCTX-M-15 should be considered for the current clinical
management and antibiotic policies, investigated further
and controlled to prevent major outbreaks in future.
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